FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
EXMceuticals Inc. Stock AnalysisComprehensive stock analysis for EXMceuticals Inc. (EXM.CN) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisEXM.CN
EXM.CN
EXMceuticals Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
EXM.CN
Home🔹Stocks🔹EXMceuticals Inc.

EXMceuticals Inc.

EXM.CN•CNQ

EXMceuticals Inc.

EXM.CN•CNQ
Market cap
$15.15M
Sentiment

Your view on EXM.CN

Mkt Cap
$15.15M
Sentiment
Your view
EXM.CN
EXMceuticals Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
EXM.CN
Company Overview

Overview

What the company does, where it operates, and who runs it.

About EXMceuticals Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Julie Lemieux
Headquarters
CA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Julie Lemieux
Headquarters
CA
Description

EXMceuticals Inc. engages in the production of cannabinoid formulations. The company primarily focuses around the matching of natural bioactive ingredients extracted from the cannabis plant with the needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries. It focuses on the production of CBD, a non-psychoactive cannabinoid that has been proven effective against acne, anxiety, depression, epilepsy, and degenerative diseases, such as Parkinson's; and THC, a psychoactive cannabinoid ingredient that has been proven effective in the fields of pain management, appetite control, anxiety, and managing side effects of chemotherapy. The company was incorporated in 2008 and is headquartered in Quebec, Canada.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News